ROYALTY PHARMA PLC
COM · CUSIP 67709Q104
1
institutional holders
16.6k
shares reported held*
$655.9kreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $39.51.
Biggest buyers
| Aubrey Capital Management Ltd | New | +16.6k |
Biggest sellers
| None |
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| Aubrey Capital Management Ltd 0.53% of their portfolio | 16.6k $655.9k | New |